Complete Filing Data
Kalaris Therapeutics, Inc. reported Stockholders Equity of $78.81 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Kalaris Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$43.4M | -$69.2M | -$190.4M | -$168.7M | -$172.0M | -$69.8M | -$23.8M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $6.0K | $0.00 | $406.0K | -$313.0K | $1.0K | -$90.0K | $68.0K |
| Other Nonoperating Income Expense | $2.7M | $188.0K | $3.6M | $351.0K | -$2.5M | $195.0K | $797.0K |
| Operating Income Loss | -$46.2M | -$51.7M | -$199.9M | -$171.2M | -$169.8M | -$71.3M | -$26.7M |
| General And Administrative Expense | $15.4M | $6.7M | $48.3M | $52.3M | $49.1M | $21.6M | $10.6M |
| Other Comprehensive Income Loss Net Of Tax | $6.0K | $0.00 | $406.0K | -$313.0K | -$43.0K | -$180.0K | $68.0K |
| Comprehensive Income Net Of Tax | -$43.4M | -$69.2M | -$190.0M | -$169.0M | -$172.0M | -$70.0M | -$23.8M |
| Research And Development Expense | $30.8M | $45.0M | $133.1M | $118.9M | $120.7M | $49.7M | $16.2M |
| Operating Expenses | $46.2M | $51.7M | $199.9M | $171.2M | $169.8M | $71.3M | $26.9M |
| Income Tax Expense Benefit | $0.00 | -$126.0K | -$265.0K | $1.0M | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$58.8M | -$190.5M | -$169.0M | -$171.0M | -$69.8M | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$44.0K | -$90.0K | |||||
| Income Taxes Paid Net | $220.0K | $613.0K | |||||
| Research And Development Income Expense | |||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $165.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$11.9M | -$11.4M | -$10.2M | -$38.1M | -$5.7M | -$3.4M | -$44.3M | -$45.3M | -$41.2M | -$42.1M | -$44.6M | -$43.9M | -$45.5M | -$37.6M | -$30.9M | -$23.6M | -$11.6M | -$9.3M | -$7.3M | -$5.3M | -$2.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $6.0K | $0.00 | -$1.0K | -$76.0K | $25.0K | $76.0K | $167.0K | -$119.0K | -$94.0K | -$195.0K | -$3.0K | -$16.0K | $42.0K | -$125.0K | -$134.0K | $176.0K | -$27.0K | $129.0K | |||
| Other Nonoperating Income Expense | $847.0K | $906.0K | $193.0K | $31.0K | $66.0K | $27.0K | $1.2M | $521.0K | $723.0K | $210.0K | -$27.0K | -$818.0K | -$259.0K | -$408.0K | -$565.0K | $174.0K | $355.0K | $44.0K | $427.0K | $140.0K | |
| Operating Income Loss | -$12.7M | -$12.3M | -$10.4M | -$37.8M | -$4.2M | -$2.6M | -$47.0M | -$47.3M | -$43.2M | -$43.0M | -$44.6M | -$43.2M | -$45.5M | -$37.7M | -$30.9M | -$23.9M | -$12.2M | -$9.8M | -$8.5M | -$5.9M | |
| General And Administrative Expense | $3.6M | $3.8M | $4.3M | $1.8M | $976.0K | $602.0K | $12.8M | $12.5M | $12.5M | $12.9M | $13.2M | $14.1M | $12.4M | $12.0M | $10.5M | $6.7M | $3.3M | $3.0M | $2.8M | $3.2M | |
| Other Comprehensive Income Loss Net Of Tax | $6.0K | $0.00 | -$1.0K | -$76.0K | $25.0K | $76.0K | $167.0K | -$119.0K | -$94.0K | -$195.0K | -$108.0K | -$38.0K | $125.0K | -$151.0K | -$134.0K | $176.0K | -$27.0K | $129.0K | |||
| Comprehensive Income Net Of Tax | -$11.9M | -$38.1M | -$6.1M | -$30.4M | -$44.2M | -$45.2M | -$41.0M | -$42.2M | -$44.7M | -$44.1M | -$45.6M | -$37.6M | -$30.8M | -$23.8M | -$11.8M | -$9.2M | -$7.3M | -$5.2M | |||
| Research And Development Expense | $9.1M | $8.4M | $6.0M | $36.0M | $3.2M | $2.0M | $34.2M | $34.8M | $30.7M | $30.0M | $31.4M | $29.1M | $33.1M | $25.7M | $20.4M | $17.2M | $8.9M | $6.8M | $5.7M | $2.8M | |
| Operating Expenses | $12.7M | $12.3M | $10.4M | $37.8M | $4.2M | $2.6M | $47.0M | $47.3M | $43.2M | $43.0M | $44.6M | $43.2M | $45.5M | $37.7M | $30.9M | $23.9M | $12.2M | $9.8M | $8.5M | $5.9M | |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $150.0K | $0.00 | $0.00 | |||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$44.3M | -$45.3M | -$42.1M | -$44.5M | -$43.9M | -$45.5M | -$37.6M | ||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $0.00 | -$105.0K | -$22.0K | $83.0K | -$26.0K | ||||||||||||||||
| Income Taxes Paid Net | $500.0K | ||||||||||||||||||||
| Research And Development Income Expense | $246.0K | -$34.2M | |||||||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $78.8M | -$96.6M | -$45.0M | $224.5M | $225.3M | $353.1M | -$51.5M | -$30.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $98.6M | $1.6M | $3.2M | $106.9M | $202.5M | $122.7M | $61.1M | $25.0M |
| Cash And Cash Equivalents At Carrying Value | $98.1M | $1.6M | $90.1M | $106.1M | $201.7M | $122.7M | $61.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $96.9M | -$1.5M | -$16.0M | -$95.6M | $79.9M | $61.6M | $36.1M | |
| Retained Earnings Accumulated Deficit | -$160.0M | -$116.6M | -$656.2M | -$465.8M | -$297.1M | -$125.1M | -$55.3M | |
| Prepaid Expense And Other Assets Current | $827.0K | $967.0K | $3.5M | $7.1M | $5.2M | $4.5M | $676.0K | |
| Liabilities Current | $9.7M | $24.7M | $28.4M | $24.3M | $37.9M | $12.3M | $9.1M | |
| Liabilities And Stockholders Equity | $121.7M | $6.2M | $190.8M | $277.1M | $286.6M | $370.8M | $139.4M | |
| Liabilities | $42.9M | $56.8M | $45.0M | $52.6M | $61.3M | $17.8M | $17.8M | |
| Assets Current | $118.8M | $2.6M | $187.6M | $243.1M | $253.3M | $361.3M | $127.3M | |
| Assets | $121.7M | $6.2M | $190.8M | $277.1M | $286.6M | $370.8M | $139.4M | |
| Accounts Payable Current | $1.3M | $1.6M | $6.8M | $3.0M | $8.4M | $963.0K | $630.0K | |
| Short Term Investments | $19.9M | $0.00 | $93.8M | $127.7M | $46.5M | $233.7M | $65.0M | |
| Common Stock Value | $2.0K | $0.00 | $0.00 | $9.0K | $7.0K | $7.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $6.0K | $0.00 | -$62.0K | -$468.0K | -$155.0K | -$112.0K | $68.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $98.6M | $1.6M | $91.0M | $106.9M | $202.5M | $122.7M | ||
| Interest Receivable Current | $0.00 | $206.0K | $157.0K | $50.0K | $450.0K | $262.0K | ||
| Accrued Liabilities Current | $5.0M | $10.1M | $14.0M | $20.2M | $7.5M | $5.2M | ||
| Operating Lease Right Of Use Asset | $1.5M | $0.00 | $2.2M | $31.6M | $29.7M | $8.7M | $11.8M | |
| Operating Lease Liability Noncurrent | $1.1M | $0.00 | $16.6M | $28.2M | $23.5M | $5.5M | $8.7M | |
| Operating Lease Liability Current | $316.0K | $0.00 | $10.8M | $7.2M | $6.6M | $3.2M | $3.1M | |
| Restricted Cash Noncurrent | $499.0K | $0.00 | $852.0K | $852.0K | $852.0K | |||
| Restricted Cash | $499.0K | $0.00 | $852.0K | $852.0K | $852.0K | |||
| Other Assets Noncurrent | $953.0K | $410.0K | $122.0K | $612.0K | $1.1M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $399.0K | $1.3M | $3.7M | $1.1M | -$1.2M | |||
| Property Plant And Equipment Net | $930.0K | $1.5M | $812.0K | $350.0K | ||||
| Non Cash Lease Income Expense | -$145.0K | -$7.9M | ||||||
| Non Cash Lease Expense | $7.9M | $1.8M | $928.0K | |||||
| Taxes Payable Current | $128.0K | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $41.9M | $53.1M | $63.9M | -$89.4M | -$51.5M | -$47.5M | $195.3M | $229.1M | $193.5M | $253.2M | $158.1M | $191.7M | $267.3M | $302.5M | $330.4M | $373.9M | -$71.3M | -$60.0M | -$43.3M | -$36.6M | -$32.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $42.9M | $88.9M | $101.5M | $1.9M | $6.2M | $5.2M | $96.5M | $197.8M | $116.6M | $124.7M | $71.9M | $101.1M | $244.0M | $225.4M | $168.6M | $142.3M | $78.6M | $64.4M | $35.1M | $41.4M | |
| Cash And Cash Equivalents At Carrying Value | $42.4M | $88.4M | $101.0M | $1.9M | $6.2M | $5.2M | $95.6M | $197.0M | $115.7M | $123.8M | $71.1M | $100.2M | $243.2M | $225.4M | $168.6M | $142.3M | $78.3M | $168.6M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $99.8M | $2.1M | $9.6M | -$101.5M | $46.0M | $3.3M | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$150.0M | -$138.1M | -$126.8M | -$696.7M | -$692.6M | -$686.5M | -$596.5M | -$552.2M | -$507.0M | -$427.6M | -$385.6M | -$385.6M | -$239.1M | -$193.6M | -$156.0M | -$99.9M | -$76.3M | ||||
| Prepaid Expense And Other Assets Current | $1.2M | $3.2M | $1.2M | $626.0K | $230.0K | $771.0K | $5.9M | $4.7M | $7.5M | $5.6M | $3.8M | $4.9M | $5.9M | $2.3M | $2.2M | $4.9M | $2.4M | ||||
| Liabilities Current | $6.1M | $7.7M | $7.1M | $1.4M | $2.4M | $7.7M | $33.1M | $30.6M | $25.0M | $20.7M | $21.6M | $18.6M | $24.2M | $20.7M | $15.5M | $13.5M | $8.9M | ||||
| Liabilities And Stockholders Equity | $81.2M | $92.8M | $103.1M | $122.5M | $131.0M | $144.1M | $248.3M | $282.7M | $244.0M | $293.7M | $200.0M | $231.1M | $316.5M | $327.5M | $351.3M | $393.7M | $117.8M | ||||
| Liabilities | $39.3M | $39.7M | $39.2M | $1.4M | $10.7M | $23.7M | $53.0M | $53.6M | $50.5M | $40.5M | $41.9M | $39.4M | $49.2M | $25.0M | $20.9M | $19.8M | $16.0M | ||||
| Assets Current | $78.2M | $91.7M | $102.2M | $122.5M | $129.9M | $141.5M | $220.0M | $252.9M | $212.3M | $272.0M | $176.5M | $206.4M | $281.9M | $316.0M | $339.7M | $383.9M | $107.3M | ||||
| Assets | $81.2M | $92.8M | $103.1M | $122.5M | $131.0M | $144.1M | $248.3M | $282.7M | $244.0M | $293.7M | $200.0M | $231.1M | $316.5M | $327.5M | $351.3M | $393.7M | $117.8M | ||||
| Accounts Payable Current | $494.0K | $3.7M | $2.4M | $51.0K | $110.0K | $765.0K | $3.9M | $5.2M | $4.1M | $4.9M | $5.5M | $4.5M | $133.0K | $4.2M | $2.1M | $1.8M | $680.0K | ||||
| Short Term Investments | $34.6M | $5.0M | $24.9M | $54.5M | $117.7M | $49.6M | $86.9M | $140.3M | $101.6M | $101.2M | $32.7M | $87.9M | $168.3M | $236.2M | $26.2M | ||||||
| Common Stock Value | $2.0K | $2.0K | $2.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $9.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $6.0K | -$134.0K | -$139.0K | -$138.0K | -$200.0K | -$225.0K | -$301.0K | -$563.0K | -$444.0K | -$350.0K | -$133.0K | -$25.0K | $13.0K | -$41.0K | $110.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $42.9M | $88.9M | $101.5M | $1.9M | $6.2M | $5.2M | $96.5M | $197.8M | $116.6M | $124.7M | $71.9M | $101.1M | $244.0M | $225.4M | $168.6M | $142.3M | |||||
| Interest Receivable Current | $53.0K | $96.0K | $181.0K | $234.0K | $106.0K | $244.0K | $261.0K | $91.0K | $172.0K | $151.0K | $409.0K | $469.0K | $423.0K | $58.0K | |||||||
| Accrued Liabilities Current | $1.4M | $1.6M | $4.6M | $15.9M | $16.7M | $12.3M | $13.7M | $13.1M | $10.1M | $15.8M | $10.0M | $7.9M | $7.8M | $4.5M | |||||||
| Operating Lease Right Of Use Asset | $1.5M | $495.0K | $2.1M | $25.3M | $27.5M | $29.6M | $19.1M | $20.8M | $21.7M | $31.5M | $9.6M | $10.7M | $9.5M | $10.2M | |||||||
| Operating Lease Liability Noncurrent | $1.2M | $8.3M | $16.0M | $19.9M | $23.0M | $25.6M | $19.8M | $20.3M | $20.8M | $25.1M | $4.3M | $5.4M | $6.3M | $7.1M | |||||||
| Operating Lease Liability Current | $376.0K | $667.0K | $2.3M | $13.0M | $8.5M | $8.3M | $1.9M | $2.2M | $2.4M | $6.3M | $4.8M | $4.8M | $3.2M | $3.1M | |||||||
| Restricted Cash Noncurrent | $500.0K | $500.0K | $500.0K | $554.0K | $554.0K | $852.0K | $852.0K | $852.0K | $852.0K | $852.0K | $852.0K | $852.0K | $0.00 | ||||||||
| Restricted Cash | $500.0K | $500.0K | $500.0K | $554.0K | $554.0K | $852.0K | $852.0K | $852.0K | $852.0K | $852.0K | $852.0K | $852.0K | |||||||||
| Other Assets Noncurrent | $976.0K | $691.0K | $410.0K | $1.4M | $684.0K | $490.0K | $734.0K | $857.0K | $979.0K | $1.2M | $692.0K | ||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $745.0K | $729.0K | -$76.0K | ||||||||||||||||||
| Property Plant And Equipment Net | $673.0K | $759.0K | $844.0K | $943.0K | $997.0K | $1.1M | $1.1M | $1.2M | $869.0K | $295.0K | $313.0K | ||||||||||
| Non Cash Lease Income Expense | -$80.0K | -$461.0K | |||||||||||||||||||
| Non Cash Lease Expense | $461.0K | $380.0K | $54.0K | ||||||||||||||||||
| Taxes Payable Current | $0.00 | $127.0K | $130.0K | $154.0K | $154.0K | $507.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $1.9M | $895.0K | $40.8M | $41.3M | $44.0M | $9.4M | $2.9M |
| Net Cash Provided By Used In Operating Activities | -$38.4M | -$20.7M | -$124.5M | -$142.1M | -$106.3M | -$60.8M | -$20.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.8M | $803.0K | -$5.6M | $3.0M | $1.2M | $3.9M | $620.0K |
| Net Cash Provided By Used In Investing Activities | -$19.7M | $95.0M | $38.0M | -$80.5M | $186.0M | -$169.5M | -$64.6M |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $15.0M | $95.0M | $163.8M | $148.3M | $262.6M | $131.0M | $55.0M |
| Increase Decrease In Accrued Interest Receivable Net | -$206.0K | $49.0K | $107.0K | -$400.0K | $188.0K | $262.0K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$28.9M | -$2.5M | -$12.6M | $20.3M | $2.7M | $4.9M | |
| Net Cash Provided By Used In Financing Activities | $155.0M | $19.1M | $70.5M | $127.0M | $232.0K | $292.0M | $120.9M |
| Payments To Acquire Available For Sale Securities Debt | $34.5M | $125.8M | $228.8M | $76.6M | $300.3M | $119.3M | |
| Increase Decrease In Other Noncurrent Assets | $355.0K | $410.0K | $900.0K | -$490.0K | $1.1M | ||
| Depreciation Depletion And Amortization | $398.0K | $723.0K | $189.0K | $73.0K | $19.0K | ||
| Proceeds From Stock Plans | $21.0K | $326.0K | $536.0K | ||||
| Increase Decrease In Income Taxes | -$128.0K | -$879.0K | $1.0M | ||||
| Proceeds From Issuance Initial Public Offering | $70.2M | $295.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $374.0K | $31.0K | $10.0M | $10.5M | $8.1M | $646.0K |
| Net Cash Provided By Used In Operating Activities | -$7.4M | -$4.5M | -$32.1M | -$46.5M | -$18.9M | -$10.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.4M | $395.0K | $333.0K | -$284.0K | -$1.7M | $284.0K |
| Net Cash Provided By Used In Investing Activities | $40.0M | $41.7M | -$55.0M | $64.8M | $13.8M | |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $40.0M | $53.5M | $6.0M | $95.0M | $35.0M | |
| Increase Decrease In Accrued Interest Receivable Net | -$26.0K | $87.0K | $122.0K | $19.0K | $49.0K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$15.7M | -$486.0K | -$13.8M | $1.7M | -$1.5M | |
| Net Cash Provided By Used In Financing Activities | $107.3M | $6.6M | ||||
| Payments To Acquire Available For Sale Securities Debt | $11.8M | $61.0M | $30.1M | $21.2M | ||
| Increase Decrease In Other Noncurrent Assets | -$122.0K | -$122.0K | -$122.0K | |||
| Depreciation Depletion And Amortization | $86.0K | $466.0K | $18.0K | $18.0K | ||
| Proceeds From Stock Plans | ||||||
| Increase Decrease In Income Taxes | $2.0K | -$500.0K | ||||
| Proceeds From Issuance Initial Public Offering |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.85 | -$51.77 | -$42.09 | -$2.20 | -$2.74 | -$2.59 | -$18.54 |
| Common Stock Shares Authorized | 300.0M | 86.0M | 150.0M | 150.0M | 150.0M | 150.0M | 90.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 15.3M | 1.3M | 4.5M | 76.7M | 62.8M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 15.3M | 1.3M | 4.5M | 76.7M | 62.8M | ||
| Earnings Per Share Basic | $-2.85 | $-51.77 | $-42.09 | $-2.20 | $-2.74 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 22.9M | 1.4M | 5.0M | 93.1M | 63.6M | 61.9M | 2.1M |
| Common Stock Shares Issued | 22.9M | 1.4M | 5.0M | 93.3M | 65.2M | 65.1M | 6.5M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 62.8M | 26.9M | 1.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.64 | -$0.61 | -$2.52 | -$28.16 | -$4.26 | -$2.60 | -$0.39 | -$0.48 | -$0.44 | -$0.50 | -$0.69 | -$0.69 | -$0.72 | -$0.60 | -$0.50 | -$0.58 | -$4.43 | -$4.21 | -$4.97 | -$5.05 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 90.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 18.7M | 18.7M | 4.1M | 1.4M | 1.3M | 1.3M | 113.9M | 94.6M | 93.3M | 84.9M | 64.5M | 64.0M | 63.0M | 62.3M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 18.7M | 18.7M | 4.1M | 1.4M | 1.3M | 1.3M | 113.9M | 94.6M | 93.3M | 84.9M | 64.5M | 64.0M | 63.0M | 62.3M | |||||||
| Earnings Per Share Basic | $-0.64 | $-0.61 | $-2.52 | $-28.16 | $-4.26 | $-2.60 | $-0.39 | $-0.48 | $-0.44 | $-0.50 | $-0.69 | $-0.69 | $-0.72 | $-0.60 | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 0.00 | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 18.7M | 18.7M | 18.7M | 115.4M | 115.3M | 114.9M | 114.0M | 113.7M | 93.4M | 92.6M | 64.8M | 64.3M | 63.2M | 62.8M | 62.5M | 61.7M | 2.8M | ||||
| Common Stock Shares Issued | 18.7M | 18.7M | 18.7M | 115.4M | 115.3M | 114.9M | 114.0M | 113.7M | 93.5M | 93.1M | 65.6M | 65.4M | 65.1M | 65.1M | 65.1M | 65.1M | 6.6M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 64.0M | 63.0M | 62.3M | 62.2M | 40.5M | 2.6M | 2.2M | 1.5M | 1.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.9M | $895.0K | $40.8M | $41.3M | $44.0M | $9.4M | $2.9M |
| Investment Income Interest | $5.5M | $5.7M | $1.9M | $1.3M | $1.3M | $2.1M | |
| Additional Paid In Capital | $238.8M | $19.9M | $802.0M | $690.8M | $522.5M | $478.3M | $3.7M |
| Unrealized Gain Loss On Available For Sale Securities | -$73.0K | $406.0K | -$313.0K | $1.0K | -$90.0K | $68.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $21.0K | $326.0K | $536.0K | ||||
| Due To Related Parties Current | $1.7M | $572.0K | $246.0K | ||||
| Stock Issued During Period Value New Issues | $39.2M | $70.2M | $126.4M | $292.0M | |||
| Operating Income Expenses |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $638.0K | $591.0K | $374.0K | $262.0K | $322.0K | $31.0K | $10.5M | $10.3M | $10.0M | $10.9M | $11.0M | $10.5M | $10.3M | $9.7M | $8.1M | $3.9M | $492.0K | $646.0K | $596.0K | $1.4M | $231.0K | |
| Investment Income Interest | $1.5M | $1.4M | $1.2M | $1.5M | $1.5M | $1.3M | $668.0K | $162.0K | $148.0K | $253.0K | $475.0K | $505.0K | $112.0K | $166.0K | $457.0K | $781.0K | $503.0K | |||||
| Additional Paid In Capital | $191.9M | $191.2M | $190.6M | $817.9M | $813.0M | $807.1M | $792.0M | $781.6M | $700.8M | $681.4M | $544.1M | $532.9M | $506.6M | $496.1M | $486.4M | $473.8M | $4.9M | |||||
| Unrealized Gain Loss On Available For Sale Securities | -$76.0K | $167.0K | -$195.0K | $42.0K | $176.0K | |||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $21.0K | $315.0K | $244.0K | |||||||||||||||||||
| Due To Related Parties Current | $61.0K | $136.0K | $56.0K | $81.0K | $563.0K | $1.2M | $1.9M | $1.7M | $779.0K | $641.0K | $542.0K | |||||||||||
| Stock Issued During Period Value New Issues | $70.2M | $126.4M | $292.0M | |||||||||||||||||||
| Operating Income Expenses | -$5.7M | -$47.0M |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.